More than 70% of Bio-Rad's market value has been erased since its late-2021 peak, creating the opening for an activist push aimed at lifting the stock price.
The exact size of Elliott's holding was not disclosed in the report, but the campaign centers on a company currently valued at about $6.7 billion.
The move extends Elliott's pattern of taking meaningful positions in underperforming companies and pressing for changes to unlock shareholder value.
Will activist investor Elliott force Bio-Rad to sell its valuable Sartorius stake to boost its stock?
As Bio-Rad’s stock plummets, will Elliott’s arrival spark a strategic overhaul or a complete company breakup?